Cerus (CERS) FCF Margin Growth (3y) (2013 - 2026)
Cerus (CERS) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.34 Bn | 196.74 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 125.99 Bn | 122.52 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.73 Bn | 47.47 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 35.18 Bn | 33.23 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.81 Bn | 31.70 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 60.00 |
| 10 | Cerus | 568.60 Mn | 512.34 Mn | 29.53 Mn | 1,814.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,814.00 |
| Mar 31, 2026 | 6,534.00 |
| Dec 31, 2025 | 528.00 |
| Sep 30, 2025 | 4,011.00 |
| Jun 30, 2025 | -53,334.00 |
| Mar 31, 2025 | 14,351.00 |
| Dec 31, 2024 | 698.00 |
| Sep 30, 2024 | 59,513.00 |
| Jun 30, 2024 | 6,056.00 |
| Mar 31, 2024 | 18,486.00 |
| Dec 31, 2023 | 186.00 |
| Sep 30, 2023 | -661,634.00 |
| Jun 30, 2023 | 3,361.00 |
| Mar 31, 2023 | 637,886.00 |
| Dec 31, 2022 | 15,451.00 |
| Sep 30, 2022 | 570,009.00 |
| Jun 30, 2022 | 37,597.00 |
| Mar 31, 2022 | 41,445.00 |
| Dec 31, 2021 | 4,461.00 |
| Sep 30, 2021 | -7,905.00 |